Severe COVID-19 seems to correlate with an early defective Th1 response linked to an increased Th2 response in the context of a cytokine dysregulation, with an increase in interleukin (IL)-13, IL-5, eotaxin-2, IgE, and eosinophils [18,19]. This evidence concerns the gene IL13 and COVID-19.